Pomerantz Roger - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Nov 25, 2024, Pomerantz Roger's relationship to Viracta Therapeutics, Inc. (VIRX) is Director, and currently has 126,478 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VIRX insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Pomerantz Roger - Insider Non-Derivative Transactions of VIRX Common Stock
Pomerantz Roger - Insider Non-Derivative Transactions at VIRX
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 26, 2024 | M -- (Common Stock) | 9034 | 0 | 126478 |
| Aug 26, 2024 | M -- (Common Stock) | 9034 | 0 | 117444 |
| May 26, 2024 | M -- (Common Stock) | 9035 | 0 | 108410 |
| Feb 26, 2024 | M -- (Common Stock) | 9034 | 0 | 99375 |
| Nov 26, 2023 | M -- (Common Stock) | 9034 | 0 | 90341 |
| Aug 26, 2023 | M -- (Common Stock) | 9034 | 0 | 81307 |
| May 26, 2023 | M -- (Common Stock) | 9035 | 0 | 72273 |
| Feb 26, 2023 | M -- (Common Stock) | 9034 | 0 | 63238 |